Org.nr 994 297 422 2022 → 2023 Year-over-year analysis

THOR MEDICAL ASA: årsregnskap 2023 vs 2022

Slipped into loss, cash halved-plus, fresh owner capital

approved 2024-04-11; registry 2024-08-19; journal 2024 720553

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2023 with 2022 for THOR MEDICAL ASA. Revenue 0 NOK → 0 NOK (0.0%). Net result 0 NOK → -2.85m NOK. Equity 53.22m NOK → 274.63m NOK.

On the constructive side: equity strengthened; owners injected capital. Pressures included: operating result weakened; fell into a net loss; cash fell.

Also worth watching: book investments changed. All figures are taken from the published annual accounts for THOR MEDICAL ASA.

Scorecard

Revenue
0 NOK 0 NOK
0.0%
Operating result
0 NOK -4.36m NOK
—
Net result
0 NOK -2.85m NOK
—
Equity
53.22m NOK 274.63m NOK
+416.0%
Cash
84.94m NOK 40.42m NOK
-52.4%
Total assets
95.30m NOK 278.41m NOK
+192.1%

What improved

  • ↑

    Equity strengthened

    Book equity 53.22m NOK → 274.63m NOK (equity ratio 55.8% → 98.6%). Calculated

  • ↑

    Owners injected capital

    Paid-in equity rose 55.62m NOK → 292.78m NOK (+237.15m NOK). Reported fact

What deteriorated

  • ↓

    Operating result weakened

    Operating result 0 NOK → -4.36m NOK. Calculated

  • ↓

    Fell into a net loss

    Net result flipped from 0 NOK profit to a loss of 2.85m NOK. Calculated

  • ↓

    Cash fell

    Bank deposits 84.94m NOK → 40.42m NOK (-52.4% YoY). Calculated

Things to notice

  • ·

    Book investments changed

    Investment / intangible book value 137.0k NOK → 234.7k NOK. Reported fact